Delivery Order 75N93019D00016-75N93025F00001
Award Date
12/16/24
Potential Completion Date
12/15/25
Potential Value
$560K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Birmingham, AL 35294, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Delivery Order to the University of Alabama at Birmingham (UAB), doing business as U A B, for a "COMPREHENSIVE PANEL FOR VIRUSES" contract with a ceiling value of $1,053,577.42. The contract is under the broader In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery Contract (IDC) and has a completion date of September 29, 2016. UAB is a non-profit, public research university...
The University of Alabama at Birmingham (UAB) was awarded a $1,082 Firm Fixed Price delivery order contract by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct in vitro assessments of antimicrobial activity. This contract is part of the "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC) for NIAID. UAB, a public research university and academic medical center, has significant expertise in biomedical research, healthcare...
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the University of Alabama at Birmingham (UAB) on August 22, 2017. The contract has a potential value of $845,508.52 and a completion date of September 15, 2018. The contract is for in vitro assessment for antimicrobial activity and a comprehensive viral screening panel. This delivery order is...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the University of Alabama at Birmingham (UAB) for a Comprehensive Viral Screening Panel to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses. The contract is a Delivery Order under the "In Vitro Assessments of Antimicrobial Activity (IVAAA)"...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a Delivery Order contract to the University of Alabama at Birmingham (UAB) to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses. The contract is a Firm Fixed Price type awarded under the larger In Vitro Assessments of Antimicrobial Activity (IVAAA) Indefinite Delivery Contract (IDC). The contract has a ceiling value of $548,829.16 and a...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) to provide in vitro assessments for antimicrobial activity. The contract, valued at $12,178, is a delivery order under the larger "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC) vehicle. The award has a completion date of November 14, 2013,...
This federal contract award, with an ID of HHSN272201100016I|HHSN27200013, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The contract is for "IN VITRO ASSESSMENT FOR ANTIMICROBIAL ACTIVITY" and was awarded to the University of Alabama at Birmingham (UAB), a public research university, on September 13, 2016. The contract has a ceiling value of $1,066,560.00 and runs through September 15, 2017. It is a...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $499,760.00 firm fixed-price delivery order contract to the University of Alabama at Birmingham (UAB) for in vitro assessments of antimicrobial activity. This contract is under the parent "In Vitro Assessments of Antimicrobial Activity (IVAAA)" Indefinite Delivery Contract (IDC). UAB, a non-profit, state-controlled institution of higher...
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) as a Delivery Order. The contract is for "IN VITRO ASSESSMENTS FOR ANTIMICROBIAL ACTIVITY" and is part of the larger "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $1,277,140.50 and a...
This is a Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) for in vitro assessment of antimicrobial activity. The contract has a ceiling value of $1,282,905.51 and was awarded on September 17, 2012, with a completion date of September 16, 2013. The contract is under a larger Indefinite Delivery Contract (IDC) vehicle named "In Vitro Antimicrobial...